Overview

Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This study is phase 3 study for prevention of VTE in patients with abdominal surgery.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fondaparinux
PENTA